Torralba M - Search Results

1

Machine Learning-Based Assessment of Survival and Risk Factors in Non-Alcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma for Optimized Patient Management.

Suárez M, Gil-Rojas S, Martínez-Blanco P, Torres AM, Ramón A, Blasco-Segura P, Torralba M, Mateo J. Suárez M, et al. Among authors: torralba m. Cancers (Basel). 2024 Mar 10;16(6):1114. doi: 10.3390/cancers16061114. Cancers (Basel). 2024. PMID: 38539449 Free PMC article.

2

Prognostic Factors for Mortality in Hepatocellular Carcinoma at Diagnosis: Development of a Predictive Model Using Artificial Intelligence.

Martínez-Blanco P, Suárez M, Gil-Rojas S, Torres AM, Martínez-García N, Blasco P, Torralba M, Mateo J. Martínez-Blanco P, et al. Among authors: torralba m. Diagnostics (Basel). 2024 Feb 13;14(4):406. doi: 10.3390/diagnostics14040406. Diagnostics (Basel). 2024. PMID: 38396445 Free PMC article.

3

Application of Machine Learning Techniques to Assess Alpha-Fetoprotein at Diagnosis of Hepatocellular Carcinoma.

Gil-Rojas S, Suárez M, Martínez-Blanco P, Torres AM, Martínez-García N, Blasco P, Torralba M, Mateo J. Gil-Rojas S, et al. Among authors: torralba m. Int J Mol Sci. 2024 Feb 7;25(4):1996. doi: 10.3390/ijms25041996. Int J Mol Sci. 2024. PMID: 38396674 Free PMC article.

4

Anti-PD-1/PD-L1 Based Combination Immunotherapy to Boost Antigen-Specific CD8⁺ T Cell Response in Hepatocellular Carcinoma.

Peña-Asensio J, Calvo H, Torralba M, Miquel J, Sanz-de-Villalobos E, Larrubia JR. Peña-Asensio J, et al. Among authors: torralba m. Cancers (Basel). 2021 Apr 16;13(8):1922. doi: 10.3390/cancers13081922. Cancers (Basel). 2021. PMID: 33923463 Free PMC article. Review.

5

HBsAg level defines different clinical phenotypes of HBeAg(-) chronic HBV infection related to HBV polymerase-specific CD8⁺ cell response quality.

Peña-Asensio J, Calvo-Sánchez H, Miquel-Plaza J, Sanz-de-Villalobos E, González-Praetorius A, Delgado-Fernandez A, Torralba M, Larrubia JR. Peña-Asensio J, et al. Among authors: torralba m. Front Immunol. 2024 Mar 13;15:1352929. doi: 10.3389/fimmu.2024.1352929. eCollection 2024. Front Immunol. 2024. PMID: 38545116 Free PMC article.

6

IL-15 boosts activated HBV core-specific CD8⁺ progenitor cells via metabolic rebalancing in persistent HBV infection.

Peña-Asensio J, Calvo-Sánchez H, Miquel J, Sanz-de-Villalobos E, González-Praetorius A, Torralba M, Larrubia JR. Peña-Asensio J, et al. Among authors: torralba m. iScience. 2023 Dec 7;27(1):108666. doi: 10.1016/j.isci.2023.108666. eCollection 2024 Jan 19. iScience. 2023. PMID: 38155778 Free PMC article.

7

Effectiveness, durability and safety of dolutegravir and lamivudine versus bictegravir, emtricitabine and tenofovir alafenamide in a real-world cohort of HIV-infected adults.

Mendoza I, Lázaro A, Espinosa A, Sánchez L, Horta AM, Torralba M. Mendoza I, et al. Among authors: torralba m. PLoS One. 2023 Sep 29;18(9):e0291480. doi: 10.1371/journal.pone.0291480. eCollection 2023. PLoS One. 2023. PMID: 37773939 Free PMC article.

8

Model to predict on-treatment restoration of functional HBV-specific CD8⁺ cell response foresees off-treatment HBV control in eAg-negative chronic hepatitis B.

Peña-Asensio J, Calvo H, Miquel J, Sanz-de-Villalobos E, González-Praetorius A, Torralba M, Larrubia JR. Peña-Asensio J, et al. Among authors: torralba m. Aliment Pharmacol Ther. 2022 Jun;55(12):1545-1559. doi: 10.1111/apt.16850. Epub 2022 Feb 27. Aliment Pharmacol Ther. 2022. PMID: 35224746 Free PMC article.

9

Effectiveness, Durability, and Safety of Dolutegravir and Lamivudine Versus Dolutegravir, Lamivudine, and Abacavir in a Real-Life Cohort of HIV-Infected Adults.

Mendoza I, Lázaro A, Torralba M. Mendoza I, et al. Among authors: torralba m. Ann Pharmacother. 2022 Apr;56(4):412-421. doi: 10.1177/10600280211034176. Epub 2021 Jul 22. Ann Pharmacother. 2022. PMID: 34293960

10

Letter: the probability to predict HBV-specific CD8+ cell response derived from HLA-A2+ may not foresee the functional cure well in Asian off-therapy cohort-authors' reply.

Peña-Asensio J, Calvo H, Miquel J, Sanz-de-Villalobos E, González-Praetorius A, Torralba M, Larrubia JR. Peña-Asensio J, et al. Among authors: torralba m. Aliment Pharmacol Ther. 2022 Oct;56(8):1312-1313. doi: 10.1111/apt.17212. Aliment Pharmacol Ther. 2022. PMID: 36168258 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

204 results

Search Page